Intestinal Lipid Absorption

Textbook of Gastroenterology, Fifth Edition

Volumn 1, Issue , 2009, Pages 445-463

  Sun, William ^a   Lo, Chun Min ^a   Tso, Patrick ^a  

^a UNIVERSITY OF CINCINNATI MEDICAL CENTER   (United States)

Author keywords

Dietary lipid intracellular metabolism; Dietary lipids and lumenal digestion; Intestinal lipid absorption and dietary lipid types; Intestinal lipid transport clinical disorders; Micellar solubilization and dietary lipids uptake; Micellar solubilization and uptake of dietary lipids by enterocytes; Micellar solubilization importance

Indexed keywords

EID: 84889997775     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9781444303254.ch18     Document Type: Chapter

References (288)

1. Thomson ABR, Keelan M, Garg ML, Clandinin MT. Intestinal aspects of lipid absorption: in review. Can J Physiol Pharmacol 1989; 67: 179.
2. Nutting DF, Kumar NS, St Hilaire RJ, Mansbach CM. Nutrient absorption. Curr Opin Clin Nutr Metab Care 1999; 2: 413.
3. Hussain MM. A proposed model for the assembly of chylomicrons. Atherosclerosis 2000; 148: 1.
4. Ros E. Intestinal absorption of triglyceride and cholesterol. Dietary and pharmacological inhibition to reduce cardiovascular risk. Atherosclerosis 2000; 151: 357.
5. Borgström B. Luminal digestion of fats. In: Go VL (ed.). The Exocrine Pancreas. New York: Raven Press, 1986: 361.
6. Carey MC, Small DM. The characteristics of mixed micellar solution with particular reference to bile, Am J Med 1970; 49: 590.
7. Dawson PA, Rudel LL. Intestinal cholesterol absorption. Curr Opin Lipidol 1999; 10: 315.
8. Wang DQ. New concepts of mechanisms of intestinal cholesterol absorption. Ann Hepatol 2003; 2: 113.
9. Plosch T, Kosters A, Groen AK, Kuipers F. The ABC of hepatic and cholesterol transport. Handb Exp Pharmacol 2005; 170: 465.
10. Kannel WB, Dawber TR, Friedman GD, et al. Risk factors in coronary heart disease. An evaluation of several serum lipids as predictors of CHD. Ann Intern Med 1964; 61: 888.
11. Levy D, Kannel WB. Cardiovascular risks: new insights from Framingham. Am Heart J 1988; 116: 266.
12. Austin MA. Plasma triglyceride and coronary heart disease. Arteriosclerosis Thrombosis 1991; 11: 2.
13. Beynen AC, Kritchevsky D. Dietary fat and serum cholesterol. In: Beynan AC (ed.). Nutritional Effects on Cholesterol Metabolism. Voorthuizen: Transmodial, 1986: 1.
14. Valenzuela A, Morgado N. Trans fatty acid isomers in human health and in the food industry. Biol Res 1999; 32: 273.
15. Katan MB. Trans fatty acids and plasma lipoproteins. Nutr Rev 2000; 58: 188.
16. Babayan VK. Medium chain triglycerides and structured lipids. Lipids 1987; 22: 417.
17. Mascioli EA, Babayan VK, Bistrian BR, Blackburn GL. Novel triacylglycerols for special medical purposes. J Parenter Enteral Nutr 1988; 12: 127S.
18. Heird WC, Grundy SM, Hubbard VS. Structured lipids and their use in clinical nutrition. Am J Clin Nutr 1986; 43: 320.
19. Bell SJ, Bradley D, Forse RA, Bistrian B. The new dietary fats in health and disease. J Am Diet Assoc 1997; 97: 280.
20. Mu H, Porsgaard T. The metabolism of structured triglycerides. Prog Lipid Res 2005; 44: 430.
21. McKenna MC, Hubbard VS, Bieri JG. Linoleic acid absorption from lipid supplements in patients with cystic fibrosis with pancreatic insufficiency and in control subjects. J Pediatr Gastroenterol Nutr 1985; 4: 45.
22. Hubbard VS, McKenna MC. Absorption of safflower oil and structured lipid preparations in patients with cystic fibrosis. Lipids 1987; 22: 424.
23. Mok KT, Maiz A, Yamazaki K, et al. Structured medium-chain and long-chain triglyceride emulsions are superior to physical mixtures in sparing body protein in the burned rat. Metabolism 1984; 33: 910.
24. Swenson ES, Selleck KM, Babayan VK, et al. Persistence of metabolic effects after long-term oral feeding of a structured triglyceride derived from medium-chain triglyceride and fish oil in burned and normal rats. Metabolism 1991; 40: 484.
25. Tso P, Lee T, DeMichele SJ. Lymphatic absorption of structured triglycerides vs. physical mix in a rat model of fat malabsorption. Am J Physiol 1999; 277: G333.
26. Tso P, Lee T, DeMichele SJ. Randomized structured triglycerides increase lymphatic absorption of tocopherol and retinol compared with the equivalent physical mixture in a rat model of fat malabsorption. J Nutr 2001; 131: 2157.
27. Abrams CK, Hamosh M, Lee TC, et al. Gastric lipase: localization in the human stomach. Gastroenterology 1988; 95: 1460.
28. Hamosh M, Scanlon JW, Ganot D, et al. Fat digestion in the newborn: characterization of lipase in gastric aspirates of premature and term infants. J Clin Invest 1981; 67: 838.
29. Liao TH, Hamosh P, Hamosh M. Fat digestion by lingual lipase: mechanism of lipolysis in the stomach and upper small intestine. Pediatr Res 1984; 18: 402.
30. Cohen M, Morgan RGH, Hofmann AF. Lipolytic activity of human gastric and duodenal juice against medium-and long-chain triglycerides. Gastroenterology 1971; 60: 1.
31. Bodmer MW, Angal S, Yarraton GT, et al. Molecular cloning of a human gastric lipase and expression of the enzyme in yeast. Biochim Biophys Acta 1987; 909: 237.
32. Grand RJ, Watkins JB, Torti FM. Development of the human gastrointestinal tract: a review. Gastroenterology 1976; 70: 790.
33. Ross CAC. Fat absorption studies in the diagnosis and treatment of pancreatic fibrosis. Arch Dis Child 1955; 30: 316.
34. Armand M, Hamosh M, Philpott JR, et al. Gastric function in children with cystic fibrosis: effect of diet on gastric lipase levels and fat digestion. Pediatr Res 2004; 55: 457.
35. Carriere F, Renou C, Lopez V, et al. The specific activities of human digestive lipases measured from the in vivo and in vitro lipolysis of test meals. Gastroenterology 2000; 119: 949.
36. Senior JR. Intestinal absorption of fats. J Lipid Res 1964; 5: 495.
37. Carey MC, Small DM, Bliss CM. Lipid digestion and absorption. Annu Rev Physiol 1983; 45: 651.
38. Sarda L, Desnuelle P. Action de la lipase pancreatique sur les esters en emulsion. Biochim Biophys Acta 1958; 30: 513.
39. Benzonana G, Desnuelle P. Etude cinetique de l'action de la lipase pancreatique sur des triglycerides en emulsion. Essai d'une enzymologie en milieu heterogene. Biochim Biophys Acta 1965; 105: 121.
40. Desnuelle P. The lipase-colipase system. In: Rommel K, Goebell H (eds). Lipid Absorption: Biochemical and Clinical Aspects. Lancaster: MTP Press, 1976: 23.
41. Schönheyder F, Volquartz K. Gastric lipase in man. Acta Physiol Scand 1946; 11: 349.
42. Verger R. Enzyme kinetics of lipolysis. Methods Enzymol 1980; 64: 340.
43. James LK, Augustein LG. Absorption of enzymes at interfaces: file formation and the effect on activity. Adv Enzymol 1966; 28: 1.
44. McLaren AD, Packer L. Some aspects of enzyme reactions in heterogeneous systems. Adv Enzymol Relat Areas Mol Bio 1970; 33: 245.
45. Brockerhoff H. Substrate specificity of pancreatic lipase. Biochim Biophys Acta 1968; 159: 296.
46. Mattson FH, Beck LW. The specificity of pancreatic lipase on the primary hydroxyl groups of glycerides. J Biol Chem 1956; 219: 735.
47. Simmonds WJ. Fat absorption and chylomicron formation. In: Nelson GJ (ed.). Blood Lipids and Lipoproteins: Quantitation, Composition and Metabolism. New York: Wiley Interscience, 1972: 705.
48. DiMagno EP, Go VL, Summerskill WH. Relations between pancreatic enzyme outputs and malabsorption in severe pancreatic insufficiency. N Engl J Med 1973; 288: 813.
49. Carriere F, Grandval P, Gregory PC, et al. Does the pancreas really produce more lipase than required for fat digestion? JOP 2005; 6: 206.
50. Borgström B. On the mechanism of the hydrolysis of glycerides by pancreatic lipase. Acta Chem Scand 1953; 7: 557.
51. Mattson FH, Volpenhein RA. The digestion and absorption of triglycerides. J Biol Chem 1964; 239: 2772.
52. Mattson FH, Volpenhein RA. Hydrolysis of primary and secondary esters of glycerol by pancreatic juice. J Lipid Res 1968; 9: 79.
53. Borgström B. Influence of bile salt, pH, and time on the action of pancreatic lipase; physiological implications. J Lipid Res 1964; 5: 522.
54. Hofmann AF, Borgström B. Hydrolysis of long-chain monoglycerides in micellar solution by pancreatic lipase. Biochim Biophys Acta 1963; 70: 317.
55. Patton JS. Gastrointestinal lipid digestion. In: Johnson LR (ed.). Physiology of the Gastrointestinal Tract. New York: Raven Press, 1981: 1123.
56. Vandermeers A, Christophe J. Alpha-amylase et lipsae du pancreas de rat. Purification chromatographique, recherche du poids moleculaire et composition e acides amines. Biochim Biophys Acta 1968; 154: 110.
57. Vandermeers A, Vandermeers-Piret MC, Rathe J, Christophe J. On human pancreatic triacylglycerol lipase: isolation and some properties. Biochim Biophys Acta 1974; 370: 257.
58. Julien R, Canioni P, Rathelot J, et al. Studies on bovine pancreatic lipase and colipase. Biochim Biophys Acta 1972; 280: 215.
59. Rathelot J, Julien R, Bosc-Bierne P, et al. Horse pancreatic lipase. Interaction with colipase from various species. Biochimie 1981; 63: 227.
60. de Caro J, Boudouard J, Bonicel J, et al. Porcine pancreatic lipase. Completion of the primary structure. Biochim Biophys Acta 1981; 671: 129.
61. Plummer TH Jr, Sarda L. Isolation and characterization of the glycopeptides of porcine pancreatic lipases LA and LB. J Biol Chem 1973; 248: 7865.
62. Rathelot J, Canioni P, Bosc-Bierne I, et al. Limited trypsinolysis of porcine and equinine colipases. Biochim Biophys Acta 1981; 671: 155.
63. Chapus C, Semeriva M. Mechanism of pancreatic lipase action. 1. Interfacial activation of pancreatic lipase. Biochemistry 1976; 15: 4980.
64. Morgan RG, Barrowman J, Borgström B. The effect of sodium taurodeoxycholate and pH on the gel filtration behaviour of rat pancreatic protein and lipases. Biochim Biophys Acta 1969; 175: 65.
65. Erlanson C, Borgström B. Purification and further characterization of colipase from porcine pancreas. Biochim Biophys Acta 1972; 271: 400.
66. Sternby B, Borgström B. Purification and characterization of human pancreatic colipase. Biochim Biophys Acta 1979; 572: 235.
67. Maylie MF, Charles M, Gache C, Desnuelle P. Isolation and partial identification of a pancreatic colipase. Biochim Biophys Acta 1971; 229: 286.
68. Maylie MF, Charles M, Gache C, Desnuelle P. On porcine pancreatic colipase: large scale purification and some properties. Biochem Biophys Res Commun 1973; 52: 291.
69. Erlanson-Albertsson C. Pancreatic colipase. Structural and physiological aspects. Biochim Biophys Acta 1992; 1125: 1.
70. Freie AB, Ferrato F, Carriere F, Lowe ME. Val-407 and Ile-408 in the beta5′-loop of pancreatic lipase mediates lipase-colipase interactions in the presence of bile salt micelles. J Biol Chem 2006; 281: 7793.
71. Patton JS, Albertsson PA, Erlanson C, Borgström B. Binding of porcine pancreatic lipase and colipase in the absence of substrate studies by two-phase partition and affinity chromatography. J Biol Chem 1978; 253: 4195.
72. Arnesjö B, Nilsson A, Barrowman J, Borgström B. Intestinal digestion and absorption of cholesterol and lecithin in the human. Intubation studies with a fat-soluble reference substance. Scand J Gastroenterol 1969; 4: 653.
73. Borgström B, Dahlqvist A, Lundh G, Sjövall J. Studies of intestinal digestion and absorption in the human. J Clin Invest 1957; 36: 1521.
74. van den Bosch H, Postema NM, de Haas GH, Van Deenen LL. On the positional specificity of phospholipase A from pancreas. Biochim Biophys Acta 1965; 98: 657.
75. de Haas GH, Sarda L, Roger J. Positional specific hydrolysis of phospholipids by pancreatic lipase. Biochim Biophys Acta 1965; 106: 638.
76. de Haas GH, Postema NM, Nieuwenhuizen W, Van Deenen LLM. Purification and properties of phospholipase A from porcine pancreas. Biochim Biophys Acta 1968; 159: 103.
77. Arnesjö B, Barrowman J, Borgström B. The zymogen of phospholipase A2 in rat pancreatic juice. Acta Chem Scand 1967; 21: 2897.
78. Verheij HM, Slotboom AJ, de Haas GH. Structure and function of phospholipase A2. Rev Physiol Biochem Pharmacol 1981; 91: 91.
79. Verheij HM, Volwerk JJ, Jansen EH, et al. Methylation of histidine48 in pancreatic phospholipase A2. Role of histidine and calcium ion in the catalytic mechanism. Biochemistry 1980; 19: 743.
80. Fernandez MS, Mejia R, Zavala E. The interfacial calcium ion concentration as modulator of the latency phase in the hydrolysis of dimyristoylphosphatidylcholine liposomes by phospholipase A2. Biochem Cell Biol 1991; 69: 722.
81. Arnesjö B, Grubb A. The activation, purification, and properties of rat pancreatic juice phospholipase A2. Acta Chem Scand 1971; 25: 577.
82. Tsao FHC, Cohen H, Synder WR, et al. Multiple forms of porcine pancreatic phospholipase A2: isolation and specificity. J Supramol Structure 1973; 1: 490.
83. Puijk WC, Verheij HM, Wietzes P, de Haas GH. The amino acid sequence of the phospholipase A2 isoenzyme from porcine pancreas. Biochim Biophys Acta 1979; 580: 411.
84. Nalbone G, Lairon D, Carbonnier-Augeire M, et al. Pancreatic phospholipase A2 hydrolysis of phosphatidylcholines in various physicochemical states. Biochim Biophys Acta 1980; 620: 612.
85. de Haas GH, Slotboom AJ, Bonsen PPM, et al. Studies on phospholipase A and its zymogen from porcine pancreas. 1. The complete amino acid sequence. Biochim Biophys Acta 1970; 221: 31.
86. Puijk WC, Verheij HM, de Haas GH. The primary structure of phospholipase A2 from porcine pancreas. A reinvestigation. Biochim Biophys Acta 1977; 492: 254.
87. O'Hara O, Tamaki M, Nakamura E, et al. Dog and rat pancreatic phospholipases A2: complete amino acid sequences deduced from complementary DNAs. J Biochem 1986; 99: 773.
88. Kerfelec B, LaForge KS, Vasiloudes P, et al. Isolation and sequence of the canine pancreatic phospholipase A2 gene. Eur J Biochem 1990; 190: 299.
89. Richmond BL, Hui DY. Molecular structure and tissue-specific expression of the mouse pancreatic phospholipase A(2) gene. Gene 2000; 244: 65.
90. Subbaiah PV, Ganguly J. Studies in the phospholipases of rat intestinal mucosa. Biochem J 1970; 118: 233.
91. McIntyre, N. Cholesterol absorption. In: Rommel K, Goebell H, Bohmer R (eds). Lipid Absorption: Biochemical and Clinical Aspects. London: MTP Press Ltd, 1976: 73.
92. Albro PW, Thomas RO. Enzymatic hydrolysis of di-(2-ethylhexyl) phthalate by lipases. Biochim Biophys Acta 1973; 360: 380.
93. Momsen WE, Brockman HL. Purification and characterization of cholesterol esterase from porcine pancreas. Biochim Biophys Acta 1977; 486: 103.
94. Erlanson C. Purification, properties and substrate specificity of a carboxylesterase in pancreatic juice. Scand J Gastroenterol 1975; 10: 401.
95. Lombardo D, Guy O, Figarella C. Purification and characterization of a carboxyl ester hydrolase from human pancreatic juice. Biochim Biophys Acta 1978; 527: 142.
96. Meyer JG. Lipolytic enzymes of the human pancreas. II. Purification and properties of cholesterol ester hydrolase. Biochim Biophys Acta 1989; 1002: 89.
97. Kyger EM, Wiegand RC, Lange LG. Cloning of the bovine pancreatic cholesterol esterase/lysophospholipase. Biochem Biophys Res Commun 1989; 164: 1302.
98. Kissel JA, Fontaine RN, Turck CW, et al. Molecular cloning and expression of cDNA for rat pancreatic cholesterol esterase. Biochim Biophys Acta 1989; 1006: 227.
99. Kumar BV, Aleman-Gomez JA, Colwell N, et al. Structure of the human pancreatic cholesterol esterase gene. Biochemistry 1992; 31: 6077.
100. DiPersio LP, Fontaine RN, Hui DY. Identification of the active site serine in pancreatic cholesterol esterase by chemical modification and site-specific mutagenesis. J Biol Chem 1990; 265: 16801.
101. DiPersio LP, Fontaine RN, Hui DY. Site-specific mutagenesis of an essential histidine residue in pancreatic esterase. J Biol Chem 1991; 266: 4033.
102. DiPersio LP, Hui DY. Aspartic acid 320 is required for optimal activity of rat pancreatic cholesterol esterase. J Biol Chem 1993; 268: 300.
103. Lombardo D, Fauvel J, Guy O. Studies on the substrate specificity of a carboxyl ester hydrolase from human pancreatic juice. I. Action on carboxyl esters, glycerides and phospholipids. Biochim Biophys Acta 1980; 611: 136.
104. Hofmann AF, Borgström B. Physico-chemical state of lipids in intestinal content during their digestion and absorption. Fed Proc 1962; 21: 43.
105. Hofmann AF, Borgström B. The intraluminal phase of fat digestion in man: the lipid content of the micellar and oil phases of intestinal content obtained during fat digestion and absorption. J Clin Invest 1964; 43: 247.
106. Dietschy JM, Sallee VL, Wilson FA. Unstirred water layers and absorption across the intestinal mucosa. Gastroenterology 1971; 61: 932.
107. Wilson FA, Sallee VL, Dietschy JM. Unstirred water layers in intestine: rate determinant of fatty acid from micellar solutions. Science 1971; 174: 1031.
108. Westergaard H, Dietschy JM. The mechanism whereby bile acid micelles increase the rate of fatty acid and cholesterol uptake into the intestinal mucosal cell. J Clin Invest 1976; 58: 97.
109. Swell L, Flick DF, Field H Jr, Treadwell CR. Influence of dietary bile salts on blood cholesterol levels. Proc Soc Exp Biol Med 1953; 84: 428.
110. Gallo-Torres HE, Miller ON, Hamilton JG. Further studies on the role of bile salts in cholesterol esterification and absorption from the gut. Arch Biochem Biophys 1971; 143: 22.
111. Watt SM, Simmonds WJ. The specificity of bile salts in the intestinal absorption of micellar cholesterol in the rat. Clin Exp Pharmacol Physiol 1976; 3: 305.
112. Reynier MO, Montet JC, Gerolami A, et al. Comparative effects of cholic, chenodeoxycholic, and ursodeoxycholic acids on micellar solubilization and intestinal absorption of cholesterol. J Lipid Res 1981; 22: 467.
113. Cohen BI, Raicht RF, Mosbach EH. Sterol metabolism studies in the rat. Effects of primary bile acids (sodium taurochenodeoxycholate and sodium taurocholate) on sterol metabolism. J Lipid Res 1977; 18: 223.
114. Watt SM, Simmonds WJ. Effects of four taurine-conjugated bile acids on mucosal uptake and lymphatic absorption of cholesterol in the rat. J Lipid Res 1984; 25: 448.
115. Sylven C. Influence of blood supply on lipid uptake from micellar solution by the rat small intestine. Biochim Biophys Acta 1970; 203: 365.
116. Bhattacharyya AK, Connor WE. Beta-sitosterolemia and xanthomatosis. A newly described lipid storage disease in two sisters. J Clin Invest 1974; 53: 1033.
117. Shulman RS, Bhattacharyya AK, Connor WE, Fredrickson DS. Beta-sitosterolemia and xanthomatosis. N Engl J Med 1976; 294: 482.
118. Salen G, Shefer S, Nguyen L, et al. Sitosterolemia. Subcell Biochem 1997; 28: 453.
119. Porter HP, Saunders DR. Isolation of the aqueous phase of human intestinal contents during the digestion of a fatty meal. Gastroenterology 1971; 60: 997.
120. Patton JS, Carey MC. Watching fat digestion. Science 1979; 204: 145.
121. Stafford RJ, Carey MC. Physical-chemical nature of the aqueous lipids in intestinal content after a fatty meal: Revision of the Hofmann-Borgström Hypothesis. Clin Res 1981; 28: 511 (Abstract).
122. Mansbach CM 2nd, Newton D, Stevens RD. Fat digestion in patients with bile acid malabsorption but minimal steatorrhea. Dig Dis Sci 1980; 25: 353.
123. Porter HP, Saunders DR, Tytgat G, et al. Fat absorption in bile fistula man. A morphological and biochemical study. Gastroenterology 1971; 60: 1008.
124. Woollett LA, Wang Y, Buckley DD, et al. Micellar solubilisation of cholesterol is essential for absorption in humans. Gut 2006; 55: 197.
125. Borgström B. The micellar hypothesis of fat absorption: must it be revisited? Scand J Gastroenterol 1985; 20: 389.
126. Shoemaker DG, Nichols JW. Hydrophobic interaction of lysophospholipids and bile salts at submicellar concentrations. Biochemistry 1990; 29: 5837.
127. Shoemaker DG, Nichols JW. Interaction of lysophospholipid/taurodeoxycholate submicellar aggregates with phospholipid bilayers. Biochemistry 1992; 31: 3414.
128. Strauss EW. Electron microscopic study of intestinal fat absorption in vitro from mixed micelles containing linolenic acid, monoolein, and bile salt. J Lipid Res 1966; 7: 307.
129. Stremmel W. Uptake of fatty acids by jejunal mucosal cells is mediated by a fatty acid binding membrane protein. J Clin Invest 1988; 82: 2001.
130. Chow SL, Hollander D. A dual, concentration-dependent absorption mechanism of linoleic acid by rat jejunum in vitro. J Lipid Res 1979; 20: 349.
131. Stremmel W, Lotz G, Strohmeyer G, Berk PD. Identification, isolation, and partial characterization of a fatty acid binding protein from rat jejunal microvillous membranes. J Clin Invest 1985; 75: 1068.
132. Berk PD, Wada H, Horio Y, et al. Plasma membrane fatty acid-binding protein and mitochondrial glutamic-oxaloacetic transaminase of rat liver are related. Proc Natl Acad Sci USA 1990; 87: 3484.
133. Thurnhofer H, Hauser H. Uptake of cholesterol by small intestinal brush border membrane is protein-mediated. Biochemistry 1990; 29: 2142.
134. Thurnhofer H, Schnabel J, Betz M, et al. Cholesterol-transfer protein located in the intestinal brush-border membrane. Partial purification and characterization. Biochim Biophys Acta 1991; 1064: 275.
135. Thurnhofer H, Lipka G, Hauser H. Membrane proteins exposed on the external side of the intestinal brush-border membrane have fusogenic properties. Eur J Biochem 1991; 201: 273.
136. Lipka G, Schulthess G, Thurnhofer H, et al. Characterization of lipid exchange proteins isolated from small intestinal brush border membrane. J Biol Chem 1995; 270: 5917.
137. Wouters FS, Markman M, DeGraaf P, et al. The immunohistochemical localization of the non-specific lipid transfer protein (sterol carrier protein-2) in rat small intestine enterocytes. Biochim Biophys Acta 1995; 1259: 192.
138. Lundgren S, Carling T, Hjälm G, et al. Tissue distribution of human gp330/megalin, a putative Ca2+-sensing protein. J Histochem Cytochem 1997; 45: 383.
139. Farquhar MG. The unfolding story of megalin (gp330): now recognized as a drug receptor. J Clin Invest 1995; 96: 1184.
140. Moestrup SK, Cui S, Vorum H, et al. Evidence that epithelial glycoprotein 330/megalin mediates uptake of polybasic drugs. J Clin Invest 1995; 96: 1404.
141. Willnow TE, Goldstein JL, Orth K, et al. Low density lipoprotein receptor-related protein and gp330 bind similar ligands, including plasminogen activator-inhibitor complexes and lactoferrin, an inhibitor of chylomicron remnant clearance. J Biol Chem 1992; 267: 26172.
142. Cui S, Verroust PJ, Moestrup SK, Christensen EI. Megalin/gp330 mediates uptake of albumin in renal proximal tubule. Am J Physiol 1996; 271: F900.
143. Willnow TE, Hilpert J, Armstrong SA, et al. Defective forebrain development in mice lacking gp330/megalin. Proc Natl Acad Sci USA 1996; 93: 8460.
144. Hauser H, Dyer JH, Nandy A, et al. Identification of a receptor mediating absorption of dietary cholesterol in the intestine. Biochemistry 1998; 37: 17843.
145. Schulthess G, Compassi S, Werder M, et al. Intestinal sterol absorption mediated by scavenger receptor is competitively inhibited by amphipathic peptides and proteins. Biochemistry 2000; 39: 12623.
146. van Bennekum A, Werder M, Thuahnai ST, et al. Class B scavenger receptor-mediated intestinal absorption of dietary beta-carotene and cholesterol. Biochemistry 2005; 44: 4517.
147. Harmon CM, Luce P, Beth AH, Abrumad NA. Labeling of adipocyte membranes by sulfo-N-succinimidyl derivatives of long-chain fatty acids: inhibition of fatty acid transport. J Membr Biol 1991; 121: 261.
148. Abumrad NA, el-Maghrabi MR, Amri EZ, et al. Cloning of a rat adipocyte membrane protein implicated in binding or transport of long-chain fatty acids that is induced during preadipocyte differentiation. Homology with human CD36. J Biol Chem 1993; 268: 17665.
149. Van Nieuwenhoven FA, Verstijnen CPHJ, Abumrad NA, et al. Putative membrane fatty acid-translocase and cytoplasmic fatty acid-binding protein are co-expressed in rat heart and skeletal muscles. Biochem Biophys Res Commun 1995; 207: 747.
150. Spitsberg VL, Matitashivili E, Gorewit RC. Association and coexpression of fatty-acid-binding protein and glycoprotein CD36 in bovine mammary gland. Eur J Biochem 1995; 230: 872.
151. Poirier H, DeGrace P, Niot I, et al. Localization and regulation of the putative membrane fatty-acid transporter (FAT) in the small intestine. Comparison with fatty acid-binding proteins (FABP). Eur J Biochem 1996; 238: 368.
152. Abumrad NA, Sfeir Z, Connelly MA, Coburn C. Lipid transporters: membrane transport systems for cholesterol and fatty acids. Curr Opin Clin Nutr Metab Care 2000; 3: 255.
153. Nauli AM, Nassir F, Zheng S, et al. CD36 is important for chylomicron formation and secretion and may mediate cholesterol uptake in the proximal intestine. Gastroenterology 2006; 131: 1197.
154. Schaffer JE, Lodish HF. Expression cloning and characterization of a novel adipocyte long chain fatty acid transport protein. Cell 1994; 79: 427.
155. Stahl A, Hirsch DJ, Gimeno RE, et al. Identification of the major intestinal fatty acid transport protein. Mol Cell 1999; 4: 299.
156. Moulson CL, Martin DR, Lugus JJ, et al. Cloning of wrinkle-free, a previously uncharacterized mouse mutation, reveals crucial roles for fatty acid transport protein 4 in skin and hair development. Proc Natl Acad Sci USA 2003; 100: 5274.
157. Herrmann T, Grone HJ, Langbein L, et al. Disturbed epidermal structure in mice with temporally controlled fatp4 deficiency. J Invest Dermatol 2005; 125: 1228.
158. Hall AM, Wiczer BM, Herrmann T, et al. Enzymatic properties of purified murine fatty acid transport protein 4 and analysis of acyl-CoA synthetase in tissues from FATP4 null mice. J Biol Chem 2005; 280: 11948.
159. Murata M, Peränen J, Schreiner R, et al. VIP21/caveolin is a cholesterol-binding protein. Proc Natl Acad Sci USA 1995; 92: 10339.
160. Parton RG. Ultrastructural localization of gangliosides; GM1 is concentrated in caveolae. J Histochem Cytochem 1994; 42: 155.
161. Rothberg KG, Ying YS, Kamen BA, Anderson RGW. Cholesterol controls the clustering of the glycophospholipid-anchored membrane receptor for 5-methyltetrahydrofolate. J Cell Biol 1990; 111: 2931.
162. Ying YS, Anderson RGW, Rothberg KG. Each caveola contains multiple glycosyl-phosphatidylinositol-anchored membrane proteins. Cold Spring Harb Symp Quant Biol 1992; 57: 593.
163. Anderson RGW, Kamen BA, Rothberg KG, Lacey SW. Potocytosis: sequestration and transport of small molecules by caveolae. Science 1992; 255: 410.
164. Van Heek M, France CF, Compton DS, et al. In vivo metabolism-based discovery of a potent cholesterol absorption inhibitor, SCH58235, in the rat and rhesus monkey through the identification of the active metabolites of SCH48461. J Pharmacol Exp Ther 1997; 283: 157.
165. Van Heek M, Compton DS, Davis HR. The cholesterol absorption inhibitor, ezetimibe, decreases diet-induced hypercholesterolemia in monkeys. Eur J Pharmacol 2001; 415: 79.
166. Thurnhofer H, Hauser H. Uptake of cholesterol by small intestinal brush border membrane is protein-mediated. Biochemistry 1990; 29: 2142.
167. Thurnhofer H, Schnabel J, Betz M, et al. Cholesterol-transfer protein located in the intestinal brush-border membrane. Partial purification and characterization. Biochim Biophys Acta 1991; 1064: 275.
168. Berk PD, Wada H, Horio Y, et al. Plasma membrane fatty acid-binding protein and mitochondrial glutamic-oxaloacetic transaminase of rat liver are related. Proc Natl Acad Sci USA 1990; 87: 3484.
169. Wouters FS, Markman M, DeGraaf P, et al. The immunohistochemical localization of the non-specific lipid transfer protein (sterol carrier protein-2) in rat small intestine enterocytes. Biochim Biophys Acta 1995; 1259: 192.
170. Schulthess G, Compassi S, Werder M, et al. Intestinal sterol absorption mediated by scavenger receptors is competitively inhibited by amphipathic peptides and proteins. Biochemistry 2000; 39: 12623.
171. van Heek M, Farley C, Compton DS, et al. Comparison of the activity and disposition of the novel cholesterol absorption inhibitor, SCH58235, and its glucuronide, SCH60663. Br J Pharmacol 2000; 129: 1748.
172. Altmann SW, Davis HR, Zhu LJ, et al. Niemann-Pick C1 like protein is critical for intestinal cholesterol absorption. Science 2004; 303: 1201.
173. Davies JP, Scott C, Oishi K, et al. Inactivation of NPC1L1 causes multiple lipid transport defects and protects against diet-induced hypercholesterolemia. J Biol Chem 2005; 280: 12710.
174. Davis HR Jr, Zhu LJ, Hoos LM, et al. Niemann-Pick C1 Like 1 (NPC1L1) is the intestinal phytosterol and cholesterol transporter and a key modulator of whole-body cholesterol homeostasis. J Biol Chem 2004; 279: 33586.
175. Garcia-Calvo M, Lisnock J, Bull HG, et al. The target of ezetimibe is Niemann-Pick C1-Like 1 (NPC1L1). Proc Natl Acad Sci USA 2005; 102: 8132.
176. Iyer SP, Yao X, Crona JH, et al. Characterization of the putative native and recombinant rat sterol transporter Niemann-Pick C1 Like 1 (NPC1L1) protein. Biochim Biophys Acta 2005; 1722: 282.
177. Repa JJ, Turley SD, Lobaccaro JMA, et al. Regulation of absorption and ABC1-mediated efflux of cholesterol by RXR heterodimers. Science 2000; 289: 1524.
178. Berge KE, Tian H, Graf GA, et al. Accumulation of dietary cholesterol in sitosterolemia caused by mutations in adjacent ABC transporters. Science 2000; 290: 1771.
179. Lee MH, Lu K, Hazard S, et al. Identification of a gene ABCG5, important in the regulation of dietary cholesterol absorption. Nat Genet 2001; 27: 79.
180. Wang DQ. Regulation of intestinal cholesterol absorption. Annu Rev Physiol 2007; 69: 221.
181. Ockner RK, Manning JA. Fatty acid binding protein in small intestine. Identification, isolation and evidence for its role in cellular fatty acid transport. J Clin Invest 1974; 54: 326.
182. Ockner RK, Manning JA, Poppenhausen RB, Ho WK. A binding protein for fatty acids in cytosol intestinal mucosa, liver, myocardium, and other tissues. Science 1972; 177: 56.
183. Glatz JFC, Veerkamp JH. Intracellular fatty acid-binding proteins. Int J Biochem 1985; 17: 13.
184. Bass NM. The cellular fatty acid-binding proteins: aspects of structure, regulation, and function. Int Rev Cytol 1988; 111: 143.
185. Bansal MP, Cook RG, Danielson KG, Medina D. A 14-kilodalton selenium-binding protein in mouse liver is fatty acid-binding protein. J Biol Chem 1989; 264: 13780.
186. Cistola DP, Sacchettini JC, Banaszak LJ, et al. Fatty acid interactions with rat intestinal and liver fatty acid-binding proteins expressed in Escherichia coli. A comparative 13C NMR study. J Biol Chem 1989; 264: 2700.
187. Storch J, Thumser AF. The fatty acid transport function of fatty acid-binding proteins. Biochim Biophys Acta 2000; 1486: 28.
188. Shaughnessy S, Smith ER, Kodukula S, et al. Adipocyte metabolism in adipocyte fatty acid binding protein knockout mice (aP2-/-) after short-term high-fat feeding: functional compensation by the keratinocyte fatty acid binding protein. Diabetes 2000; 49: 904.
189. Vassileva G, Huwyler L, Poirier K, et al. The intestinal fatty acid binding protein is not essential for dietary fat absorption in mice. FASEB J 2000; 14: 2040.
190. Agellon LB, Toth MJ, Thomson AB. Intracellular lipid binding proteins of the small intestine. Mol Cell Biochem 2002; 239: 79.
191. Newberry EP, Xie Y, Kennedy SM, et al. Protection against Western diet-induced obesity and hepatic steatosis in liver fatty-acid binding protein knockout mice. Hepatology 2006; 44: 1191.
192. Noland BJ, Arebalo RE, Hansburg E, Scallen TJ. Purification and properties of sterol carrier protein 2. J Biol Chem 1980; 255: 4282.
193. Scallen TJ, Seetharam B, Srikantaiah MV, et al. Sterol carrier protein hypothesis: requirement for three substrate-specific soluble proteins in liver cholesterol biosynthesis. Life Sci 1975; 16: 853.
194. Srikantaiah MV, Hansbury E, Loughram ED, Scallen TJ. Purification and properties of sterol carrier protein 1. J Biol Chem 1976; 251: 5496.
195. Scallen TJ, Noland BJ, Gavey KL, et al. Sterol carrier protein 2 and fatty acid-binding protein. J Biol Chem 1985; 260: 4733.
196. Vahouny GV, Dennis P, Chanderbhan R, et al. Sterol carrier protein 2 (SCP2) mediated transfer of cholesterol to mitochondrial inner membranes. Biochem Biophys Res Commun 1984; 122: 509.
197. Leonard AN, Cohen DE. Submicellar bile salts stimulate phosphatidylcholine transfer activity of sterol carrier protein 2. J Lipid Res 1998; 39: 1981.
198. Starodub O, Jolly CA, Atshaves BP, et al. Sterol carrier protein-2 localization in endoplasmic reticulum and role in phospholipid formation. Am J Physiol 2000; 279: C1259.
199. Murphy EJ. Sterol carrier protein-2 expression increases NBDstearate uptake and cytoplasmic diffusion in L cells. Am J Physiol 1998; 275: G237.
200. Wirtz KW, Wouters FS, Bastiaens PH, et al. The non-specific lipid transfer protein (sterol carrier protein 2) acts as a peroxisomal fatty acid-CoA binding protein. Biochem Soc Trans 1998; 26: 374.
201. Johnston JM. Triglyceride biosynthesis in the intestinal mucosa. In: Rommel K, Goebell K, Bohmer R (eds). Lipid Absorption: Biochemical and Clinical Aspects. London: MTP Press, 1976: 85.
202. Kuksis A, Manganaro F. Biochemical characterization and purification of intestinal acylglycerol acyltransferases. In: Kuksis A (ed.). Fat Absorption. Boca Raton: CRC Press, 1986: 233.
203. Rao GA, Johnston JM. Purification and properties of triglyceride synthetase from the intestinal mucosa. Biochim Biophys Acta 1966; 125: 465.
204. Lehner R, Kuksis A. Triacylglycerol synthesis by purified triacylglycerol synthetase of rat intestinal mucosa. Role of acyl-CoA acyltransferase. J Biol Chem 1995; 270: 13630.
205. Smith SJ, Cases S, Jensen DR, et al. Obesity resistance and multiple mechanisms of triglyceride synthesis in mice lacking Dgat. Nat Genet 2000; 25: 87.
206. Oelkers P, Tinkelenberg A, Erdenize N, et al. A lecithin cholesterol acyltransferase-like gene mediates diacylglycerol esterification in yeast. J Biol Chem 2000; 275: 15609.
207. Bell RM, Ballas LM, Coleman RA. Lipid topogenesis. J Lipid Res 1981; 22: 391.
208. Atkinson D, Small DM. Recombinant lipoproteins: implications for structure and assembly of native lipoproteins. Annu Rev Biophys Biophys Chem 1986; 15: 403.
209. Wetterau JR, Zilversmit DB. A triglyceride and cholesteryl ester transfer protein associated with liver microsomes. J Biol Chem 1984; 259: 10863.
210. Wetterau JR, Zilversmit DB. Purification and characterization of microsomal triglyceride and cholesteryl ester transfer protein from bovine liver microsomes. Chem Phys Lipids 1985; 38: 205.
211. Wetterau JR, Zilversmit DB. Localization of intracellular triacylglycerol and cholesteryl ester transfer activity in rat tissues. Biochim Biophys Acta 1986; 875: 610.
212. Polheim D, David JSK, Schultz FM, et al. Regulation of triglyceride biosynthesis in adipose and intestinal tissue. J Lipid Res 1973; 14: 415.
213. Nilsson Å. Intestinal absorption of lecithin and lysolecithin by lymph fistula rats. Biochim Biophys Acta 1968; 152: 379.
214. Sato Y. The metabolic fate of lysolecithin administered into rat duodenal lumen. Tohuku J Exp Med 1970; 100: 227.
215. Scow RO, Stein Y, Stein O. Incorporation of dietary lecithin and lysolecithin into lymph chylomicrons in the rat. J Biol Chem 1967; 242: 4919.
216. Subbaiah PV, Sastry PS, Ganguly J. Acylation of lysolecithin in the intestinal mucosa of rats. Biochem J 1970; 118: 241.
217. Ottolenghi A. Estimation and subcellular distribution of lecithinase activity in rat intestinal mucosa. J Lipid Res 1964; 5: 532.
218. Le Kim D, Betzing H. Intestinal absorption of polyunsaturated phosphatidylcholine in the rat. Hoppe-Seylers Z Physiol Chem 1976; 357: 1321.
219. Erbland JF, Marinetti GV. The enzymatic acylation and hydrolysis of lysolecithin. Biochim Biophys Acta 1965; 106: 128.
220. Spady DK, Turley SD, Dietschy JM. Receptor-independent low density lipoprotein transport in the rat in vivo. Quantitation, characterization, and metabolic consequences. J Clin Invest 1985; 76: 1113.
221. Turley SD, Anderson JM, Dietschy JM. Rates of sterol synthesis and uptake in the major organs of the rat in vivo. J Lipid Res 1981; 22: 551.
222. Anderson JM, Turley SD, Dietschy JM. Relative rates of sterol synthesis in the liver and various extrahepatic tissues of normal and cholesterol-fed rabbits. Biochim Biophys Acta 1982; 711: 421.
223. Spady DK, Dietschy JM. Sterol synthesis in vivo in 18 tissues of the squirrel monkey, guinea pig, rabbit, hamster, and rat. J Lipid Res 1983; 24: 303.
224. Feldman EB, Russell BS, Chen R, et al. Dietary saturated fatty acid content affects lymph lipoproteins: studies in the rat. J Lipid Res 1983; 24: 967.
225. Stange EF, Dietschy JM. The origin of cholesterol in the mesenteric lymph of the rat. J Lipid Res 1985; 26: 175.
226. Pool C, Nutting DF, Simmonds WJ, Tso P. Effect of Pluronic L-81, a hydrophobic surfactant, on intestinal mucosal cholesterol homeostasis. Am J Physiol 1991; 261: G256.
227. Dietschy JM, Spady DK, Stange EF. Quantitative importance of different organs for cholesterol synthesis and low-density-lipoprotein degradation. Biochem Soc Trans 1983; 11: 639.
228. Spady DK, Bilheimer DW, Dietschy JM. Rates of receptor-dependent and -independent low density lipoprotein uptake in the hamster. Proc Natl Acad Sci USA 1983; 80: 3499.
229. Thomson ABR, Dietschy JM. Intestinal lipid absorption: major extracellular and intracellular events. In: Johnson LR (ed.). Physiology of the Gastrointestinal Tract. New York: Raven Press, 1981: 1147.
230. Clark SB, Tercyak AM. Reduced cholesterol transmucosal transport in rats with inhibited mucosal acyl CoA: cholesterol acyltransferase and normal pancreatic function. J Lipid Res 1984; 25: 148.
231. Gallo LL, Newbill T, Hyun J, Vahouny GV. Role of pancreatic cholesterol esterase in the uptake and esterification of cholesterol by isolated intestinal cells. Proc Soc Exp Biol Med 1977; 156: 277.
232. Borja CR, Vahouny GV, Treadwell CR. Role of bile and pancreatic juice in cholesterol absorption and esterification. Am J Physiol 1964; 206: 223.
233. Norum KR, Helgerud P, Peterson LB, et al. Influence of diets on acyl-CoA: cholesterol acyltransferase in villous and crypt cells from rat small intestinal mucosa and in the liver. Biochim Biophys Acta 1983; 751: 153.
234. Norum KR, Lilljeqvist AC, Drevon DA. Coenzyme-A-dependent esterification of cholesterol in intestinal mucosa from guinea-pig. Scand J Gastroenterol 1977; 12: 281.
235. Field FJ, Cooper AD, Erickson SK. Regulation of rabbit intestinal acid acyl coenzyme A-cholesterol acyltransferase in vivo and in vitro. Gastroenterology 1982; 83: 873.
236. Helgerud P, Saarem K, Norum KR. Acyl-CoA: cholesterol acyltransferase in human small intestine: its activity and some properties of the enzymic reaction. J Lipid Res 1981; 22: 271.
237. Gallo LL, Chiang Y, Vahouny GV, Treadwell CR. Localization and origin of rat intestinal cholesterol esterase determined by immunocytochemistry. J Lipid Res 1980; 21: 537.
238. Field FJ. Intestinal cholesterol esterase: intracellular enzyme or contamination of cytosol by pancreatic enzymes. J Lipid Res 1984; 25: 389.
239. Helgerud P, Haugen R, Norum KR. The effect of feeding and fasting on the activity of acyl-CoA: cholesterol acyltransferase in rat small intestine. Eur J Clin Invest 1982; 12: 493.
240. Watt SM, Simmonds WJ. The effect of pancreatic diversion on lymphatic absorption and esterification of cholesterol in the rat. J Lipid Res 1981; 22: 157.
241. Fukushima H, Aono S, Nakamura Y, et al. The effect of N-(alphamethylbenzyl)linoleamide on cholesterol metabolism in rats. J Atheroscler Res 1969; 10: 403.
242. Harnett KM, Walsh CT, Zhang L. Effects of Bay o 2752, a hypocholesterolemic agent on intestinal taurocholate absorption and cholesterol esterification. J Pharmacol Exp Ther 1989; 251: 502.
243. Tso P, Morshed KM, Nutting DF. Importance of acyl CoA-cholesterol acyltransferase (ACAT) in the esterification of cholesterol by enterocytes. FASEB J 1991; 5: A709. (Abstract).
244. Lee HT, Roark WH, Picard JA, et al. Inhibitors of acyl-CoA: cholesterol O-acyltransferase (ACAT) as hypocholesterolemic agents: synthesis and structure-activity relationships of novel series of sulfonamides, acylphosphonamides and acylphosphoramidates. Bioorg Med Chem Lett 1998; 8: 289.
245. Chang CC, Chen J, Thomas MA, et al. Regulation and immunolocalization of acyl-coenzyme A: cholesterol acyltransferase in mammalian cells as studied with specific antibodies. J Biol Chem 1995; 270: 29532.
246. Chang CC, Sakashita N, Ornvold K, et al. Immunological quantitation and localization of ACAT-1 and ACAT-2 in human liver and small intestine. J Biol Chem 2000; 275: 28083.
247. Miyazaki A, Sakashita N, Lee O, et al. Expression of ACAT-1 protein in human atherosclerotic lesions and cultured human monocytemacrophages. Arterioscler Thromb Vasc Biol 1998; 18: 1568.
248. Buhman KK, Accad M, Novak S, et al. Resistance to diet-induced hypercholesterolemia and gallstone formation in ACAT-2 deficient mice. Nat Med 2000; 6: 1341.
249. Murphy S, Albright E, Mathur SN, Field FJ. Effect of eicosapentaenoic acid on triacylglycerol transport in CaCo-2 cells. Biochim Biophys Acta 1990; 1045: 147.
250. Kam NT, Albright E, Mathur SN, Field FJ. Inhibition of acylcoenzyme A: cholesterol acyltransferase activity in CaCo-2 cells results in intracellular triglyceride accumulation. J Lipid Res 1989; 30: 371.
251. Kam NT, Albright E, Mathur SN, Field FJ. Effect of lovastatin on acyl-CoA: cholesterol acyltransferase (ACAT) activity and the basolateral-membrane secretion of newly synthesized lipids by CaCo-2 cells. Biochem J 1990; 272: 427.
252. Traber MG, Kayden HJ, Rindler MJ. Polarized secretion of newly synthesized lipoproteins by the Caco-2 human intestinal cell line. J Lipid Res 1987; 28: 1350.
253. Murphy S, Albright E, Mathur SN, et al. Apolipoprotein B mRNA abundance is decreased by eicosapentaenoic acid in CaCo-2 cells. Effect on the synthesis and secretion of apolipoprotein B. Arterioscler Thromb 1992; 12: 691.
254. Ockner RK, Hughes FB, Isselbacher KJ. Very low density lipoproteins in intestinal lymph: role in triglyceride and cholesterol transport during fat absorption. J Clin Invest 1969; 48: 2367.
255. Ockner RK, Manning JA. Fatty acid binding protein in small intestine. Identification, isolation and evidence for its role in cellular fatty acid transport. J Clin Invest 1974; 54: 326.
256. Tso P, Drake DS, Black DD, Sabesin SM. Evidence for separate pathways of chylomicron and very low density lipoprotein assembly and transport by rat small intestine. Am J Physiol 1984; 247: G599.
257. Zilversmit DB. The composition and structure of lymph chylomicrons in dog, rat, and man. J Clin Invest 1965; 44: 1610.
258. Lindgren FT, Jensen LC, Hatch FT. The isolation and quantitative analysis of serum lipoproteins. In: Nelson GJ (ed.). Blood, Lipids, and Lipoproteins: Quantitation, Composition and Metabolism. New York: Wiley, 1972: 181.
259. Mahley RW, Bennett BD, Morre DJ, et al. Lipoproteins associated with Golgi apparatus isolated from epithelial cells of rat small intestine. Lab Invest 1971; 25: 435.
260. Vahouny GV, Blendermann EM, Gallo LL, Treadwell CR. Differential transport of cholesterol and oleic acid in lymph lipoproteins: sex differences in puromycin sensitivity. J Lipid Res 1980; 21: 415.
261. Tso P, Balint JA, Bishop MB, Rodgers JB. Acute inhibition of intestinal lipid transport by Pluronic L-81 in the rat. Am J Physiol 1981; 241: G487.
262. Tso P, Balint JA, Rodgers JB. Effect of hydrophobic surfactant (Pluronic L-81) on lymphatic lipid transport in the rat. Am J Physiol 1980; 239: G348.
263. Tso P, Drake DS, Black D, Sabesin SM. Evidence for separate pathways of chylomicrons and very-low density lipoprotein assembly and secretion by rat small intestine. Am J Physiol 1984; 247: G599.
264. Nutting D, Hall J, Barrowman JA, Tso P. Further studies on the mechanism of inhibition of intestinal chylomicron transport by Pluronic L-81. Biochim Biophys Acta 1989; 1004: 357.
265. Luchoomun J, Hussain MM. Assembly and secretion of chylomicrons by differentiated cells: nascent triglycerides and preformed phospholipids are preferentially used for lipoprotein assembly. J Biol Chem 1999; 274: 19565.
266. Hussain MM, Kancha RK, Zhou Z, et al. Chylomicron assembly and catabolism: role of apolipoproteins and receptors. Biochim Biophys Acta 1996; 1300: 151.
267. Trotter PJ, Storch J. Fatty acid esterification during differentiation of the human intestinal cell line Caco-2. J Biol Chem 1993; 268: 10017.
268. Edge SB, Hoeg JM, Schneider PD, Brewer HB Jr. Apolipoprotein B synthesis is humans: liver synthesizes only apolipoprotein B-100. Metabolism 1985; 34: 726.
269. Glickman RM, Rogers M, Glickman JN. Apolipoprotein B synthesis by human liver and intestine in vitro. Proc Natl Acad Sci USA 1986; 83: 5296.
270. Glickman RM, Glickman JN, Magun A, Brin M. Apolipoprotein synthesis in normal and abetalipoproteinemic intestinal mucosa. Gastroenterology 1991; 101: 749.
271. Chen SH, Habib G, Yang CY, et al. Apolipoprotein B-48 is the product of a messenger RNA with an organ-specific in-frame stop codon. Science 1987; 238: 363.
272. Powell LM, Wallis SC, Pease RJ, et al. A novel form of tissue-specific RNA processing produces apolipoprotein-B48 in intestine. Cell 1987; 50: 831.
273. Kane JP, Hardman DA, Paulus HE. Heterogeneity of apolipoprotein B: isolation of a new species from human chylomicrons. Proc Natl Acad Sci USA 1980; 77: 2465.
274. Cardin AD, Witt KR, Barnhart CL, Jackson RL. Sulfhydryl chemistry and solubility properties of human plasma apolipoprotein B. Biochemistry 1982; 21: 4503.
275. Martins IJ, Sainsbury AJ, Mamo JC, Redgrave TG. Lipid and apolipoprotein B-48 transport in mesenteric lymph and the effect of hyperphagia on the clearance of chylomicron-like emulsions in insulin-deficient rats. Diabetologia 1994; 37: 238.
276. Hayashi H, Fujimoto K, Cardelli JA, et al. Fat feeding increases size, but not number of chylomicrons produced by small intestine. Am J Physiol 1990; 259: G709.
277. Davidson NO, Magun AM, Brasitus TA, Glickman RM. Intestinal apolipoprotein A-I and B-48 metabolism: effects of sustained alterations in dietary triglyceride and mucosal cholesterol flux. J Lipid Res 1987; 28: 388.
278. Isselbacher KJ, Scheig R, Plotkin GR, Caulfield JB. Congenital betalipoprotein deficiency: a hereditary disorder involving a defect in the absorption and transport of lipids. Medicine 1964; 43: 347.
279. Ways PO, Parmentier CM, Kayden HJ, et al. Studies on the absorptive defect for triglyceride in abetalipoproteinemia. J Clin Invest 1967; 46: 35.
280. Wetterau JR, Aggerbeck LP, Boume ME, et al. Absence of microsomal triglyceride transfer protein in individuals with abetalipoproteinemia. Science 1992; 256: 999.
281. Gordon DA, Jamil H. Progress towards understanding the role of microsomal triglyceride transfer protein in apolipoprotein-B lipoprotein assembly. Biochim Biophys Acta 2000; 1486: 72.
282. Sharp D, Ricci B, Kienzle B, et al. Human microsomal triglyceride transfer protein large subunit gene structure. Biochemistry 1994; 33: 9057.
283. Ohashi K, Ishibashi S, Osuga J, et al. Novel mutations in the microsomal triglyceride transfer protein gene causing abetalipoproteinemia. J Lipid Res 2000; 41: 1199.
284. Berriot-Varoqueaux N, Aggerbeck LP, Samson-Bouma M, Wetterau JR. The role of the microsomal triglyceride transfer protein in abetalipoproteinemia. Annu Rev Nutr 2000; 20: 663.
285. Roy CC, Levy E, Green PHR, et al. Malabsorption, hypocholesterolemia and fat filled enterocytes with increased intestinal apo B. Chylomicron retention disease. Gastroenterology 1987; 92: 390.
286. Dannoura AH, Berriot-Varoqueaux N, Amati P, et al. Anderson's disease: exclusion of apolipoprotein and intracellular lipid transport genes. Arterioscler Thromb Vasc Biol 1999; 19: 2494.
287. DeNigris SJ, Hamosh M, Kasbekar DK, et al. Lingual and gastric lipases: species differences in the origin of prepancreatic digestive enzymes and species differences in localization of gastric lipases. Biochim Biophys Acta 1988; 959: 38.
288. Kelly KA. Motility of the stomach and gastroduodenal junction. In: Johnson LR (ed.). Physiology of the Gastrointestinal Tract, vol. 1. New York: Raven Press, 1981: 393.